Overview
Safety and Effects of Ramipril Combined With Candesartan
Status:
Completed
Completed
Trial end date:
2006-03-01
2006-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
we hypothesized that combination therapy has additive beneficial effects to improve endothelial dysfunction and adipocytokine profiles in patients with hypertension.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Gachon University Gil Medical CenterTreatments:
Candesartan
Candesartan cilexetil
Ramipril
Criteria
Inclusion Criteria:- patients with mild to moderate hypertension
Exclusion Criteria:
- We will exclude patients with severe hypertension, unstable angina, acute myocardial
infarction, or renal insufficiency.